Ergomed PLC
LSE:ERGO

Watchlist Manager
Ergomed PLC Logo
Ergomed PLC
LSE:ERGO
Watchlist
Price: 1 346 GBX Market Closed
Market Cap: 701.1m GBX

Intrinsic Value

There is not enough data to reliably calculate the intrinsic value of ERGO.

The Intrinsic Value is calculated as the average of DCF and Relative values:

ERGO Intrinsic Value
Not Available
Base Case Scenario
Compare ERGO to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about ERGO?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Ergomed PLC

Current Assets 66.9m
Cash & Short-Term Investments 26m
Receivables 38.3m
Other Current Assets 2.6m
Non-Current Assets 66.5m
PP&E 5.2m
Intangibles 55.9m
Other Non-Current Assets 5.5m
Current Liabilities 37.3m
Accounts Payable 4.3m
Accrued Liabilities 9.5m
Other Current Liabilities 23.5m
Non-Current Liabilities 5.2m
Long-Term Debt 1.4m
Other Non-Current Liabilities 3.8m
Efficiency

Free Cash Flow Analysis
Ergomed PLC

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Ergomed PLC

Revenue
152.1m GBP
Cost of Revenue
-90.2m GBP
Gross Profit
61.9m GBP
Operating Expenses
-41.1m GBP
Operating Income
20.7m GBP
Other Expenses
-5.7m GBP
Net Income
15m GBP
Fundamental Scores

ERGO Profitability Score
Profitability Due Diligence

Ergomed PLC's profitability score is 56/100. The higher the profitability score, the more profitable the company is.

Positive 3Y Average ROIC
Positive 3Y Average ROE
Positive ROE
Positive ROIC
56/100
Profitability
Score

Ergomed PLC's profitability score is 56/100. The higher the profitability score, the more profitable the company is.

ERGO Solvency Score
Solvency Due Diligence

Ergomed PLC's solvency score is 92/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Negative Net Debt
Low D/E
92/100
Solvency
Score

Ergomed PLC's solvency score is 92/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ERGO Price Targets Summary
Ergomed PLC

There are no price targets for ERGO.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for ERGO is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y